Opus Genetics, Inc. (IRD) stock
IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$3.92−0.13 (-3.21%)
Close on Nov 18, 2026Market cap $326.13MP/E –Yield –
Opus Genetics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Opus Genetics's pe ratio was 2.1× on Jan 31, 2024.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Jan 31, 2024 | 2.1× | −0.3 |
| 2023 | Dec 29, 2023 | 2.4× | – |
See a number that looks wrong?